Recipharm has formed a collaboration with Laccure, a Helsingborg, Sweden-based project company within the life-science development company, Partners for Development Investments in Life Sciences, for the commercial manufacture and delivery of Laccure Pessary, a patented substance that releases lactic acid to treat bacterial vaginosis infection in women.

The product will be manufactured, packaged, and distributed globally from Recipharm’s facility in Karlskoga, Sweden. The date for the launch will be announced in 2017.

Source: Recipharm